Waning of 2-Dose BNT162b2 and mRNA-1273 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Accounting for Depletion-of-Susceptibles Bias

por Andrejko, Kristin L, Pry, Jake M, Myers, Jennifer F, Mehrotra, Megha, Lamba, Katherine, Lim, Esther, Fukui, Nozomi, DeGuzman, Jennifer L, Openshaw, John, Watt, James, Jain, Seema, Lewnard, Joseph A, COVID-19 Case-Control Study Team, on behalf of the California
Publicado 2023